posted on 2021-11-12, 04:31authored byYahiya Y. Syed
The Ravulizumab in Atypical
Haemolytic Uraemic Syndrome Adis Drug Evaluation video abstract, script and
image slide deck provide a brief overview of the mechanism of action of ravulizumab
in atypical haemolytic uraemic syndrome, the administration regimen and the key
efficacy and tolerability outcomes from clinical trials.
The
video abstract, script and slide deck, which have been peer reviewed and were
uploaded to Figshare after the Ravulizumab in Atypical Haemolytic Uraemic
Syndrome Adis Drug Evaluation was published, are sponsored by Alexion
Pharmaceuticals, Inc.